Related Experiment Videos
Mutations in SUFU predispose to medulloblastoma
Michael D Taylor1, Ling Liu, Corey Raffel
1Division of Neurosurgery, The Arthur and Sonia Labatt Brain Tumour Research Centre, Toronto, Canada.
Nature Genetics
|June 18, 2002
Summary
Mutations in the SUFU gene, a tumor suppressor, disrupt the sonic hedgehog (SHH) pathway, leading to medulloblastoma in children. This discovery reveals a new mechanism for SHH pathway activation in cancer.
Area of Science:
- Developmental Biology
- Oncology
- Molecular Genetics
Background:
- The sonic hedgehog (SHH) signaling pathway is crucial for embryonic development and its dysregulation is implicated in various cancers.
- Mutations in the Patched-1 (PTCH) receptor gene are linked to developmental anomalies and cancers like medulloblastoma, consistent with nevoid basal-cell carcinoma syndrome (NBCCS).
Purpose of the Study:
- To investigate the role of the SUFU gene in the SHH signaling pathway in pediatric medulloblastoma.
- To identify novel mechanisms of SHH pathway activation in cancer development.
Main Methods:
- Genetic analysis of SUFU in a subset of children with medulloblastoma.
- Assessment of mutation impact on GLI transcription factor localization and SHH pathway activity.
Main Results:
- Germline and somatic mutations in SUFU were identified in a subset of medulloblastoma patients.
- Several SUFU mutations resulted in truncated proteins that impaired GLI export from the nucleus, leading to SHH pathway activation.
- Loss of heterozygosity of the wildtype SUFU allele was observed.
Conclusions:
- SUFU acts as a tumor suppressor gene in the context of medulloblastoma.
- Mutations in SUFU contribute to medulloblastoma development by altering GLI regulation and activating the SHH signaling pathway through a novel mechanism.